NIHR Alert: Largest ever trial into a rare cancer of the urinary system shows clear benefits of chemotherapy after surgery

Commentaries are provided on a trial (n=261) reporting that 4 cycles of cisplatin or carboplatin (combined with gemcitabine), halved (reduced by 55%) the risk of upper tract urothelial cancer returning after surgery vs. regular monitoring for disease recurrence.

NIHR Evidence